HCW Biologics Inc is trading 10.6% down at $1.30 today, extending a sharp multi-day slide amid broader volatility in small-cap biotech stocks.
- The move follows an 11.0% decline during the regular trading session, where shares closed at $1.45.
- No new company-specific news, earnings reports, or regulatory filings have been issued to account for the recent price action.
- The downward trend appears driven by continued risk-off sentiment currently impacting the biotechnology sector.